Tissue Physiology of Cynomolgus Monkeys: Cross-Species Comparison and Implications for Translational Pharmacology
暂无分享,去创建一个
S. Prabhu | G. Ferl | Hanine Rafidi | N. Dybdal | C. Boswell | Jessica A. Couch | Sheila Ulufatu | Michelle G. Schweiger | S. Joseph | I. Figueroa | Amy Oldendorp | D. Mandikian | Danielle Mandikian | S. Ulufatu | Sean B. Joseph | C. A. Boswell | Jessica A. Couch
[1] Neil D. Theise,et al. Structure and Distribution of an Unrecognized Interstitium in Human Tissues , 2018, Scientific Reports.
[2] B. Krippendorff,et al. Interstitial IgG antibody pharmacokinetics assessed by combined in vivo‐ and physiologically‐based pharmacokinetic modelling approaches , 2017, The Journal of physiology.
[3] K. Scearce-Levie,et al. Widespread brain distribution and activity following i.c.v. infusion of anti‐β‐secretase (BACE1) in nonhuman primates , 2017, British journal of pharmacology.
[4] F. Cordero,et al. Biologic Data of Cynomolgus Monkeys Maintained under Laboratory Conditions , 2016, PloS one.
[5] H. Koeppen,et al. Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor , 2016, mAbs.
[6] M. Brug,et al. Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies , 2015, Neuron.
[7] A. Kjær,et al. Quantitative myocardial blood flow with Rubidium-82 PET: a clinical perspective. , 2015, American journal of nuclear medicine and molecular imaging.
[8] William J. Jusko,et al. Across-Species Scaling of Monoclonal Antibody Pharmacokinetics Using a Minimal PBPK Model , 2015, Pharmaceutical Research.
[9] K. Scearce-Levie,et al. Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates , 2014, Science Translational Medicine.
[10] J. Riviere,et al. The application of allometric scaling principles to predict pharmacokinetic parameters across species , 2014, Expert opinion on drug metabolism & toxicology.
[11] L. Khawli,et al. Comparative physiology of mice and rats: radiometric measurement of vascular parameters in rodent tissues. , 2014, Molecular pharmaceutics.
[12] H. Klein,et al. Mollison's Blood Transfusion in Clinical Medicine , 2014 .
[13] K. Scearce-Levie,et al. A Therapeutic Antibody Targeting Bace1 Inhibits Amyloid-beta Production in Vivo , 2013 .
[14] L. Khawli,et al. Vascular physiology and protein disposition in a preclinical model of neurodegeneration. , 2013, Molecular pharmaceutics.
[15] L. Khawli,et al. Differential Effects of Predosing on Tumor and Tissue Uptake of an 111In-Labeled Anti-TENB2 Antibody–Drug Conjugate , 2012, The Journal of Nuclear Medicine.
[16] F. Theil,et al. Compartmental Tissue Distribution of Antibody Therapeutics: Experimental Approaches and Interpretations , 2012, The AAPS Journal.
[17] Andreas A Linninger,et al. Interspecies scaling in pharmacokinetics: a novel whole-body physiologically based modeling framework to discover drug biodistribution mechanisms in vivo. , 2012, Journal of pharmaceutical sciences.
[18] M. Sliwkowski,et al. Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model , 2012, Molecular Cancer Therapeutics.
[19] Dhaval K. Shah,et al. Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human , 2011, Journal of Pharmacokinetics and Pharmacodynamics.
[20] Maria I. Zavodszky,et al. BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems , 2011, Journal of Pharmacokinetics and Pharmacodynamics.
[21] K. Scearce-Levie,et al. A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo , 2011, Science Translational Medicine.
[22] F. Theil,et al. Effects of Anti-VEGF on Predicted Antibody Biodistribution: Roles of Vascular Volume, Interstitial Volume, and Blood Flow , 2011, PloS one.
[23] Anna M. Wu,et al. Erratum to: A Predictive Model of Therapeutic Monoclonal Antibody Dynamics and Regulation by the Neonatal Fc Receptor (FcRn) , 2005, Annals of Biomedical Engineering.
[24] F. Theil,et al. Development and evaluation of a novel method for preclinical measurement of tissue vascular volume. , 2010, Molecular pharmaceutics.
[25] Joseph P Balthasar,et al. Physiologically based pharmacokinetic model for T84.66: a monoclonal anti-CEA antibody. , 2010, Journal of pharmaceutical sciences.
[26] Elaina M Kenyon,et al. A physiologically based pharmacokinetic model for intravenous and ingested dimethylarsinic acid in mice. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[27] W. Hayton,et al. Allometric scaling of xenobiotic clearance: Uncertainty versus universality , 2008, AAPS PharmSci.
[28] Joseph P. Balthasar,et al. Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice , 2007, Journal of Pharmacokinetics and Pharmacodynamics.
[29] Hung Q. Dam,et al. Blood Volume Analysis: A New Technique and New Clinical Interest Reinvigorate a Classic Study* , 2007, Journal of Nuclear Medicine Technology.
[30] Choong-Yong Kim,et al. Indirect indicator of transport stress in hematological values in newly acquired cynomolgus monkeys , 2005, Journal of medical primatology.
[31] W. Geldenhuys,et al. Brain Uptake Kinetics of Nicotine and Cotinine after Chronic Nicotine Exposure , 2005, Journal of Pharmacology and Experimental Therapeutics.
[32] J. Rendell,et al. Potassium transport in Langendorff‐perfused mouse hearts assessed by 87Rb NMR spectroscopy , 2005, Magnetic resonance in medicine.
[33] P. Sinko,et al. P-Glycoprotein and Mutlidrug Resistance-Associated Proteins Limit the Brain Uptake of Saquinavir in Mice , 2005, Journal of Pharmacology and Experimental Therapeutics.
[34] Robert L. Dedrick,et al. Animal scale-up , 1973, Journal of Pharmacokinetics and Biopharmaceutics.
[35] Anna M. Wu,et al. A Predictive Model of Therapeutic Monoclonal Antibody Dynamics and Regulation by the Neonatal Fc Receptor (FcRn) , 2005, Annals of Biomedical Engineering.
[36] Tim Morris,et al. Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.
[37] J. Mordenti,et al. Interspecies Scaling of Clearance and Volume of Distribution Data for Five Therapeutic Proteins , 1991, Pharmaceutical Research.
[38] V. R. McCready,et al. 99mTc-HMPAO as a tumour blood flow agent , 2004, European Journal of Nuclear Medicine.
[39] W. Bachmann,et al. In vivo/in vitro labeling of red blood cells with 99mTc , 2004, European Journal of Nuclear Medicine.
[40] D. Levitt,et al. The pharmacokinetics of the interstitial space in humans , 2003, BMC clinical pharmacology.
[41] Johan Gabrielsson,et al. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications , 2002 .
[42] S. Lindstedt,et al. Use of allometry in predicting anatomical and physiological parameters of mammals , 2002, Laboratory animals.
[43] Robin Hull,et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes , 2001, Journal of applied toxicology : JAT.
[44] D. Goldenberg,et al. Regulation of tumour drug delivery by blood flow chronobiology. , 2000, European journal of cancer.
[45] M. Delp,et al. Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.
[46] A. Tefferi,et al. Measurement of blood volume and red cell mass: re-examination of 51Cr and 125I methods. , 1996, Blood cells, molecules & diseases.
[47] R K Jain,et al. Biodistribution of monoclonal antibodies: scale-up from mouse to human using a physiologically based pharmacokinetic model. , 1995, Cancer research.
[48] R K Jain,et al. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. , 1994, Cancer research.
[49] R. Reed,et al. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. , 1993, Physiological reviews.
[50] R. Tompkins,et al. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels. , 1992, Cancer research.
[51] S. Khor,et al. Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. II. Distribution of phencyclidine in the rat. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[52] R. Youle,et al. Pharmacokinetic analysis of immunotoxin uptake in solid tumors: role of plasma kinetics, capillary permeability, and binding. , 1990, Cancer research.
[53] I. A. Watson,et al. Quantitative in vivo measurements of tumor perfusion using rubidium-81 and positron emission tomography. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[54] R. Vessella,et al. Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clouser and renal cell xenografts. , 1988, Cancer research.
[55] N. Mullani,et al. Skeletal muscle blood flow in vivo: detection with rubidium-82 and effects of glucose, insulin, and exercise. , 1987, Journal of Nuclear Medicine.
[56] J. Mordenti,et al. Man versus beast: pharmacokinetic scaling in mammals. , 1986, Journal of pharmaceutical sciences.
[57] S. R. Gautam,et al. Determination of gallium concentration in "blood-free" tissues using a radiolabeled blood marker. , 1985, Journal of pharmaceutical sciences.
[58] S. Shah,et al. Vascular volume and permeability of human and murine tumors grown in athymic mice. , 1985, Cancer letters.
[59] L. Smith,et al. Cardiac output distribution and regional blood flow during hypocarbia in monkeys. , 1985, Journal of applied physiology.
[60] M D Blaufox,et al. Blood volume in the rat. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[61] J Marshall,et al. Quantitative Measurement of Blood—Brain Barrier Permeability Using Rubidium-82 and Positron Emission Tomography , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[62] S. W. O'Connor,et al. Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors. , 1984, Cancer research.
[63] R K Jain,et al. Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.
[64] Madan M. Rehani,et al. Site of Tc-99m binding to the red blood cell: concise communication. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[65] D G Pavel,et al. In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[66] J. Vácha. Blood volume in inbred strain BALB/c, CBA/J and C57BL/10 mice determined by means of 59Fe-labelled red cells and 59Fe bound to transferrin. , 1975, Physiologia Bohemoslovaca.
[67] J. Fowler,et al. The measurement of blood perfusion in experimental tumors by uptake of 86Rb. , 1974, Cancer research.
[68] T. McMahon,et al. Size and Shape in Biology , 1973, Science.
[69] J. Sharp,et al. Blood volume determination in the mouse , 1973, The Journal of physiology.
[70] G. Denardo,et al. Blood flow in irradiated mouse sarcoma as determined by the clearance of xenon-133. , 1972, Cancer research.
[71] N. Hollenberg,et al. Cardiac output distribution in the rat: comparison of rubidium and microsphere methods. , 1971, The American journal of physiology.
[72] R. F. Johnson,et al. The significance of the total-body hematocrit in measurements of blood compartments. , 1971, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[73] S. Ayres,et al. Peripheral Vascular Volumes and Whole Body Hematocrit During Human Heart Lung Bypass , 1970, Circulation.
[74] K. Melmon,et al. Normal distribution of cardiac output in the unanesthetized, restrined rhesus monkey. , 1968, Journal of applied physiology.
[75] E. Malone,et al. Determination of Total Blood Volume from Measurements of Total Red Blood Cell Mass and Plasma Volume, using Simultaneously Injected Isotopes , 1964, Nature.
[76] P. Gullino,et al. Studies on the exchange of fluids between host and tumor. III. Regulation of blood flow in hepatomas and other rat tumors. , 1962, Journal of the National Cancer Institute.
[77] W. Dameshek,et al. The body hematocrit/venous hematocrit ratio and the "splenic reservoir". , 1961, Blood.
[78] L. Sapirstein,et al. Regional blood flow by fractional distribution of indicators. , 1958, The American journal of physiology.
[79] H. Vetter,et al. The body/venous hematocrit ratio: its constancy over a wide hematocrit range. , 1953, The Journal of clinical investigation.
[80] E. Adolph,et al. Quantitative Relations in the Physiological Constitutions of Mammals. , 1949, Science.